Alan Osborne Trounson

StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA.

The Ontario Institute For Regenerative Medicine provides stem cell and regenerative medicine research services. The company was founded by on November 25, 2014 and is headquartered in Toronto, Canada.

Maccine is a Singapore-based preclinical contract research organization providing innovative discovery research and quality safety-assessment services to the global biotechnology and pharmaceutical industry. It offers creating translational value in the preclinical research space and significant investment in technology, people and science has ensured Maccine's position at the forefront of global preclinical research. Maccine is an established preclinical contract research organization providing innovative discovery support and regulatory safety assessment services. Operating on a collaborative partnering model, Maccine has developed a portfolio of in vivo assays in key therapeutic areas including Neurology, Psychiatry, Metabolic Disorders, Pain & Inflammation, Oncology, Musculoskeletal Disorders and Women's Health. Naturalistic models, clinical biomarkers and clinical technology platforms are employed to better represent the clinical disease state. The team is supported by significant investment in high-end technology and access to a world class scientific community.

ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore.

Monash IVF Pty Ltd. provides IVF and infertility treatment for male and female. It offers artificial insemination, ovulation induction, testicular biopsy, counseling, ultrasound, embryology, donor programs and complementary care services. The company was founded in 1971 and is headquartered in Richmond, Australia.